Contrast-Enhanced Mammography–Guided Breast Biopsy: Single-Center Experience
Anat Kornecki, Mousumi Bhaduri, Nasir Khan, Ilanit Ben Nachum, Giulio Muscedere, Olga Shmuilovich, Kalan Lynn, Eni Nano, Lily Blyth
Abstract
This prospective single-center study enrolled 50 women with 51 contrast-enhanced mammography (CEM)-enhancing lesions that lacked a sonographic or mammographic correlate. Trial participants underwent CEM-guided biopsy. Biopsy was technically successful for 46 lesions and was not performed for five nonvisualized lesions (all nonmass enhancement), yielding a cancellation rate of 9.8%. Mean biopsy time was 16.6 minutes. All biopsies revealed concordant pathology (25 benign, 10 high-risk, 11 malignant). No non-visualized or benign lesion yielded malignancy at follow-up.
Topics & Concepts
MedicineBiopsyMammographyRadiologyMalignancySingle CenterBreast biopsyProspective cohort studyBreast imagingLesionBreast cancerSurgeryPathologyCancerInternal medicineBreast Cancer Treatment StudiesDigital Radiography and Breast ImagingBreast Lesions and Carcinomas